CMMBVSNRSN• 6 Months (Normalized)
CMMB vs NRSN (Chemomab Therapeutics Ltd. vs NeuroSense Therapeutics Ltd.)
Showing Closing Date Range from Apr 2 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CMMB Performance $1.67
+7.05%
Chemomab Therapeutics Ltd.
Normalized Baseline0.00%
NRSN Performance $7.4
+%
NeuroSense Therapeutics Ltd.
Normalized Baseline0.00%
Alpha Spread Margin CMMB LEADS
+7.05 pts
CMMB outperforming by 7.05 percentage points
CMMBNRSN
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CMMB NRSN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | CMMB Price | CMMB Gain (%) | NRSN Price | NRSN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $1.67 | +7.05% | $- | - | |
| Sep 28, 2026 | $1.64 | +5.13% | $- | - | |
| Sep 25, 2026 | $2.16 | +38.46% | $- | - | |
| Sep 24, 2026 | $2.20 | +41.03% | $- | - | |
| Sep 23, 2026 | $2.28 | +46.15% | $7.40 | +791.57% | -745.42% |
| Sep 22, 2026 | $2.51 | +60.90% | $7.18 | +765.06% | -704.16% |
| Sep 21, 2026 | $2.48 | +58.97% | $6.62 | +697.59% | -638.62% |
| Sep 18, 2026 | $2.61 | +67.31% | $6.35 | +665.06% | -597.75% |
| Sep 17, 2026 | $2.80 | +79.49% | $6.72 | +709.64% | -630.15% |
| Sep 16, 2026 | $2.65 | +69.87% | $6.49 | +681.93% | -612.06% |
| Sep 15, 2026 | $2.47 | +58.33% | $7.03 | +746.99% | -688.66% |
| Sep 14, 2026 | $2.45 | +57.05% | $6.90 | +731.33% | -674.28% |
| Sep 11, 2026 | $2.58 | +65.38% | $0.35 | -58.19% | +123.57% |
| Sep 10, 2026 | $2.60 | +66.67% | $0.33 | -60.00% | +126.67% |
| Sep 09, 2026 | $2.69 | +72.44% | $0.40 | -51.69% | +124.13% |
Page 1 of 9